Samuel Wagner (Warren Stevens)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Metastatic Renal Cell Carcinoma

Cross Sectional

Top Venues

PharmacoEconomics

Health economics

JCO clinical cancer informatics

This page only lists publications with an associated author ORCID identifier.

Publications

Gemma Elizabeth Shields, Paul Clarkson, Ash Bullement, Samuel Wagner, Mark Wilberforce, Tracey M Farragher, Arpana Verma, Linda M Davies
Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature. PharmacoEconomics 42 (7) (2024)
Gemma Elizabeth Shields, Paul Clarkson, Ash Bullement, Samuel Wagner, Mark Wilberforce, Tracey M Farragher, Arpana Verma, Linda M Davies
Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature. PharmacoEconomics 42 (7) (2024)
Gemma Elizabeth Shields, Paul Clarkson, Ash Bullement, Samuel Wagner, Mark Wilberforce, Tracey M Farragher, Arpana Verma, Linda M Davies
Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature. PharmacoEconomics 42 (7) (2024)
Gemma Elizabeth Shields, Paul Clarkson, Ash Bullement, Samuel Wagner, Mark Wilberforce, Tracey M Farragher, Arpana Verma, Linda M Davies
Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature. PharmacoEconomics (2024)
Alind Gupta, Paul Arora, Darren R Brenner, Jacqueline Vanderpuye-Orgle, Devon J Boyne, Mark Edmondson-Jones, Elena Parkhomenko, Warren Stevens, Shaan Dudani, Daniel Y C Heng, Samuel Wagner, John Borrill, Elise Wu
Risk Prediction Using Bayesian Networks: An Immunotherapy Case Study in Patients With Metastatic Renal Cell Carcinoma. JCO clinical cancer informatics 5 (2021)
Samuel Wagner, Devin Incerti, Desi Peneva, Anshu Shrestha, Gregory Smith, Krishnan Ramaswamy
An empirical investigation of time-varying cost-effectiveness across the product life cycle. Health economics 29 (5) (2020)